1. Home
  2. BEAM vs CSTM Comparison

BEAM vs CSTM Comparison

Compare BEAM & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • CSTM
  • Stock Information
  • Founded
  • BEAM 2017
  • CSTM 2010
  • Country
  • BEAM United States
  • CSTM France
  • Employees
  • BEAM N/A
  • CSTM N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • CSTM Metal Fabrications
  • Sector
  • BEAM Health Care
  • CSTM Industrials
  • Exchange
  • BEAM Nasdaq
  • CSTM Nasdaq
  • Market Cap
  • BEAM 1.9B
  • CSTM 1.7B
  • IPO Year
  • BEAM 2020
  • CSTM 2013
  • Fundamental
  • Price
  • BEAM $29.01
  • CSTM $10.36
  • Analyst Decision
  • BEAM Buy
  • CSTM Strong Buy
  • Analyst Count
  • BEAM 10
  • CSTM 5
  • Target Price
  • BEAM $47.67
  • CSTM $21.00
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • CSTM 1.0M
  • Earning Date
  • BEAM 11-05-2024
  • CSTM 02-19-2025
  • Dividend Yield
  • BEAM N/A
  • CSTM N/A
  • EPS Growth
  • BEAM N/A
  • CSTM N/A
  • EPS
  • BEAM N/A
  • CSTM 0.75
  • Revenue
  • BEAM $349,643,000.00
  • CSTM $7,559,669,861.00
  • Revenue This Year
  • BEAM N/A
  • CSTM N/A
  • Revenue Next Year
  • BEAM $10.82
  • CSTM $4.32
  • P/E Ratio
  • BEAM N/A
  • CSTM $13.78
  • Revenue Growth
  • BEAM 328.73
  • CSTM N/A
  • 52 Week Low
  • BEAM $20.84
  • CSTM $9.98
  • 52 Week High
  • BEAM $49.50
  • CSTM $23.20
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 56.94
  • CSTM 26.00
  • Support Level
  • BEAM $24.96
  • CSTM $9.98
  • Resistance Level
  • BEAM $29.53
  • CSTM $11.97
  • Average True Range (ATR)
  • BEAM 2.05
  • CSTM 0.40
  • MACD
  • BEAM -0.04
  • CSTM -0.15
  • Stochastic Oscillator
  • BEAM 67.05
  • CSTM 8.30

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: i) Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium products in European and North American facilities. ii) Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities. iii) The Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

Share on Social Networks: